Om mig
Lab-ansvarig Biomedicinsk analytiker på Kliniskt forskningscentrum Lab (KFC-Lab).
7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection. Marking U, Bladh O, Havervall S, Svensson J, Greilert-Norin N, Aguilera K, Kihlgren M, Salomonsson AC, Månsson M, Gallini R, Kriegholm C, Bacchus P, Hober S, Gordon M, Blom K, Smed-Sörensen A, Åberg M, Klingström J, Thålin C Lancet Infect Dis 2023 Feb;23(2):150-152
Markers of neutrophil activation and neutrophil extracellular traps in diagnosing patients with acute venous thromboembolism: A feasibility study based on two VTE cohorts. Smith P, Rosell A, Farm M, Bruzelius M, Aguilera Gatica K, Mackman N, Odeberg J, Thålin C PLoS One 2022 ;17(7):e0270865
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19. Havervall S, Ng H, Jernbom Falk A, Greilert-Norin N, Månberg A, Marking U, Laurén I, Gabrielsson L, Salomonsson AC, Aguilera K, Kihlgren M, Månsson M, Rosell A, Hellström C, Andersson E, Olofsson J, Skoglund L, Yousef J, Pin E, Lord M, Åberg M, Hedhammar M, Tegel H, Dönnes P, Phillipson M, Nilsson P, Klingström J, Mangsbo S, Hober S, Thålin C J Intern Med 2022 Jan;291(1):72-80
Response by Mackman et al to Letter Regarding Article, "Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report". Mackman N, Hisada Y, Grover SP, Rosell A, Havervall S, von Meijenfeldt F, Aguilera K, Lisman T, Thålin C Arterioscler Thromb Vasc Biol 2021 Jun;41(6):e381-e382
Prognostic value of circulating markers of neutrophil activation, neutrophil extracellular traps, coagulation and fibrinolysis in patients with terminal cancer. Rosell A, Aguilera K, Hisada Y, Schmedes C, Mackman N, Wallén H, Lundström S, Thålin C Sci Rep 2021 Mar;11(1):5074
Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19. Ng H, Havervall S, Rosell A, Aguilera K, Parv K, von Meijenfeldt FA, Lisman T, Mackman N, Thålin C, Phillipson M Arterioscler Thromb Vasc Biol 2021 Feb;41(2):988-994
Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report. Rosell A, Havervall S, von Meijenfeldt F, Hisada Y, Aguilera K, Grover SP, Lisman T, Mackman N, Thålin C Arterioscler Thromb Vasc Biol 2021 Feb;41(2):878-882
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Rudberg AS, Havervall S, Månberg A, Jernbom Falk A, Aguilera K, Ng H, Gabrielsson L, Salomonsson AC, Hanke L, Murrell B, McInerney G, Olofsson J, Andersson E, Hellström C, Bayati S, Bergström S, Pin E, Sjöberg R, Tegel H, Hedhammar M, Phillipson M, Nilsson P, Hober S, Thålin C Nat Commun 2020 Oct;11(1):5064
Quantification of citrullinated histones: Development of an improved assay to reliably quantify nucleosomal H3Cit in human plasma. Thålin C, Aguilera K, Hall NW, Marunde MR, Burg JM, Rosell A, Daleskog M, Månsson M, Hisada Y, Meiners MJ, Sun ZW, Whelihan MF, Cheek MA, Howard SA, Saxena-Beem S, Noubouossie DF, Key NS, Sheikh SZ, Keogh MC, Cowles MW, Lundström S, Mackman N, Wallén H, Johnstone AL J Thromb Haemost 2020 Oct;18(10):2732-2743
The expression of microvesicles in the blood of patients with Graves' disease and its relationship to treatment. Mobarrez F, Abraham-Nordling M, Aguilera-Gatica K, Friberg I, Antovic A, Pisetsky DS, Jörneskog G, Wallen H Clin Endocrinol (Oxf) 2016 May;84(5):729-35